AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PARADIGM BIOPHARMACEUTICALS

0.305

0.000

Volume:317.02K

Turnover:95.95K

Market Cap:132.21M

PE:-5.11

High:0.305

Open:0.305

Low:0.300

Close:0.305

52wk High:0.660

52wk Low:0.255

Shares:433.46M

Float Shares:353.07M

Volume Ratio:0.54

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.060

EPS(LYR):-0.060

ROE:-81.66%

ROA:-55.11%

PB:6.24

PE(LYR):-5.11

Loading ...

Overview Company News Filings

Company Profile

Company Name:

PARADIGM BIOPHARMACEUTICALS

Exchange:

ASX

Establishment Date:

2014

Employees:

- -

Office Location:

500 Collins Street,Level 15,Melbourne,Victoria,Australia

Website:

http://www.paradigmbiopharma.com

Zip Code:

3000

Phone:

Fax:

61 3 9629 5466

Introduction:

Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PAR.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PAR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","market":"AU","secType":"STK","nameCN":"PARADIGM BIOPHARMACEUTICALS","latestPrice":0.305,"timestamp":1770949098654,"preClose":0.305,"halted":0,"volume":317018,"delay":0,"changeRate":0,"nameEN":"PARADIGM BIOPHARMACEUTICALS","floatShares":353065639,"shares":433460088,"eps":-0.059699,"marketStatus":"Trading","change":0,"latestTime":"02-13 13:21:01 AEDT","open":0.305,"high":0.305,"low":0.3,"amount":95949,"amplitude":0.016393,"askPrice":0.305,"askSize":76196,"bidPrice":0.3,"bidSize":845189,"shortable":3,"etf":0,"ttmEps":-0.059699,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770958800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.305,"openAndCloseTimeList":[[1770937200000,1770958800000]],"volumeRatio":0.538562,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAR.AU\",,,,,undefined,":{"symbol":"PAR.AU","floatShares":353065639,"roa":"-55.11%","roe":"-81.66%","lyrEps":-0.059684,"volumeRatio":0.538562,"shares":433460088,"dividePrice":0,"high":0.305,"amplitude":0.016393,"preClose":0.305,"low":0.3,"week52Low":0.255,"pbRate":"6.24","psRate":"7916.49","week52High":0.66,"institutionHeld":0,"latestPrice":0.305,"committee":0.834606,"eps":-0.059699,"divideRate":0,"volume":317018,"delay":0,"ttmEps":-0.059699,"open":0.305,"prevYearClose":0.34,"prevWeekClose":0.29,"prevMonthClose":0.305,"prevQuarterClose":0.34,"fiveDayClose":0.29,"twentyDayClose":0.33,"sixtyDayClose":0.35,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-02-06","symbol":"PAR.AU","defaultRemindTime":1738796400000,"type":"split","dateTimestamp":1738760400000,"forFactor":4,"toFactor":5,"ratio":0.8},{"market":"AU","date":"2022-08-17","symbol":"PAR.AU","defaultRemindTime":1660694400000,"type":"split","dateTimestamp":1660658400000,"forFactor":992772,"toFactor":1000000,"ratio":0.992772}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAR.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":276414891,"yearFounded":2014,"address":"500 Collins Street,Level 15,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9629 5566","officeFax":"61 3 9629 5466"},"stockCompanyDetail":{"websiteUrl":"http://www.paradigmbiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1159},{"period":"3month","weight":-0.1029},{"period":"6month","weight":-0.0896},{"period":"1year","weight":-0.39},{"period":"ytd","weight":-0.1029}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":-0.0111},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0548},{"period":"1year","weight":0.1954},{"period":"ytd","weight":0.0094}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Paradigm Biopharmaceuticals Limited, a biopharmaceutical company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulphate sodium drugs in the injectable and tablet forms for the treatment of bone marrow edema, respiratory, and alphaviral arthritis diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.272727,"avgChangeRate":-0.065489},{"month":2,"riseRate":0.5,"avgChangeRate":0.021625},{"month":3,"riseRate":0.5,"avgChangeRate":-0.00176},{"month":4,"riseRate":0.5,"avgChangeRate":0.080809},{"month":5,"riseRate":0.5,"avgChangeRate":-0.034618},{"month":6,"riseRate":0.6,"avgChangeRate":0.067575},{"month":7,"riseRate":0.4,"avgChangeRate":-0.033426},{"month":8,"riseRate":0.545455,"avgChangeRate":0.112354},{"month":9,"riseRate":0.545455,"avgChangeRate":0.040273},{"month":10,"riseRate":0.545455,"avgChangeRate":0.131474},{"month":11,"riseRate":0.181818,"avgChangeRate":-0.081789},{"month":12,"riseRate":0.454545,"avgChangeRate":0.065089}],"exchange":"ASX","name":"PARADIGM BIOPHARMACEUTICALS","nameEN":"PARADIGM BIOPHARMACEUTICALS"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PAR.AU\",market:\"AU\",,,undefined,":null}}